New skin cell transplant combo aims to restore color in white patches
NCT ID NCT07662915
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests two surgical techniques to treat stable white patches on the skin that are not caused by vitiligo. Both methods involve transplanting the patient's own skin cells, followed by laser therapy to boost color return. Twenty-two adults will each receive both treatments on different patches to see which works better and is safer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Melanocyte keratinocyte transplantation procedure (MKTP) and 308-nm excimer laser
- What this could lead to
- If successful, this could point toward a better surgical treatment for stable white patches not caused by vitiligo, improving skin color matching and repigmentation.
- What could go wrong
- This is a very small early study with only 22 participants, so results may not apply to everyone. The procedures involve surgery and laser, which carry risks like infection or scarring.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKODERMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.